Skip to main content

Table 1 Characteristics of initiators of celecoxib or NSAIDs (ibuprofen or diclofenac) in a cohort 18–65 years old between 1 July 2003 and 30 September 2004 in the MarketScan database: age at the date of the first medication use and co-morbidities/use of medications as defined during six months prior to the first medication use

From: Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example

Characteristics

Celecoxib

n = 7,197 (38%)

Ibuprofen or Diclofenac

n = 11,632 (62%)

 

n

%

n

%

Age (years)

    

   Median

56.0

 

52.0

 

   Mean

54.1

 

50.4

 

   Standard deviation

8.2

 

9.7

 

   18-35

235

3.3

996

8.6

   36-45

854

11.9

2,164

18.6

   46-55

2,373

33.0

4,339

37.3

   56-65

3,735

51.9

4,133

35.5

Female

4,387

61.0

6,869

59.1

Hypertension

1,748

24.3

2,191

18.8

Congestive heart failure

36

0.5

56

0.5

Coronary artery disease

270

3.8

297

2.6

Chronic renal disease

44

0.6

59

0.5

Inflammatory bowel disease

26

0.4

30

0.3

Use of gastroprotective drugs

1,567

21.8

2,111

18.1

Use of warfarin

220

3.1

128

1.1

Use of antiplatelet

143

2.0

108

0.9

Use of oral steroids

963

13.4

1,356

11.7